The National Institutes of Health has introduced a study to track prevalence and have an effect on SARS-CoV-2 infection in approximately 16,000 pregnant women in seven low- and middle-income countries. months after delivery to compare the maternal, fetal and neonatal outcomes of inflamed participants with the virus with those of unin infected pregnant women.
During labor, women enrolled in the exam will get an antibody test to determine if they have been exposed to SARS-CoV-2. Researchers hope to find out if the infection increases the threat of headaches such as prematurity, delayed fetal expansion, fetal death. , newborn death and birth defects. They also hope to assess participants’ wisdom and attitudes about COVID-19 pregnancy, adding safety, protective practices, and prenatal care. The women in the exam will also be asked to participate in a follow-up investigation to find out if maternal SARS-CoV-2 infection influences the baby’s outcomes, such as cerebral palsy, developmental delays, and hearing and visual abnormalities.
It is being conducted through the Global Network for Research on Women’s and Children’s Health, an organization of clinical sites funded through the NIH National Institute of Child Health and Human Development (NICHD), Eunice Kennedy Shriver. The participating countries are Guatemala, Bangladesh, India, Pakistan, Kenya, Democratic Republic of the Congo and Zambia.
NICHD director Diana W. Bianchi, M. D. , is available for comment.
At the Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD): NICHD conducts studies and education to perceive human development, reproductive health, the lives of young people and adolescents and optimize capacity for all. For more information, visit https:///www. nichd. nih. gov.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Nih. . . Turning discovery into health®
National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892
U. S. Department of Health and Human Services